Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients.
暂无分享,去创建一个
V. Moreno | R. Salazar | P. Roepman | I. Simon | J. Tabernero | R. Rosenberg | G. Lanza | U. Nitsche | L. Stork | T. Bachleitner-Hofmann